SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trader J's Inner Circle
NVDA 184.900.0%Jan 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Trader J who wrote (12068)4/1/1999 7:05:00 AM
From: ArtAlley  Read Replies (1) of 56537
 
ASCT: I'm buying at these levels...also holding FORE & PAIR....I think that ASCT actually has 3 new drugs(if you recall the recent drug that was sent back for packaging updates) up for approval. The plus here is that the CEO has stated that his feelings that at least one of these drugs will get approval this time around. And it could come anytime now... seeing that the six month waiting period was up at the end of March. I'm certainly not an authority on FDA approvals but this is what I understand from SEC reports etc. A while back Brad Palm1 did a very nice review of these drugs and the tremendous value to ASCT as a growing company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext